Sign up to save your podcasts
Or
Share Formulation and delivery of RNA-based vaccines and therapeutics: addressing outstanding questions around safety and purity
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Formulation and delivery of RNA-based vaccines and therapeutics: addressing outstanding questions around safety and purity
In this interview, Róisin McGuigan, Editor, Nucleic Acid Insights, and Jesse Erasmus, Director of Virology at HDT Bio, discuss current challenges and opportunities in RNA safety, manufacturing, and targeted delivery, and the key ongoing obstacles facing viral and LNP-based delivery modalities.
View all episodes
By BioInsightsIn this interview, Róisin McGuigan, Editor, Nucleic Acid Insights, and Jesse Erasmus, Director of Virology at HDT Bio, discuss current challenges and opportunities in RNA safety, manufacturing, and targeted delivery, and the key ongoing obstacles facing viral and LNP-based delivery modalities.